Ferring
Ferring Pharmaceuticals, a global biopharmaceutical company headquartered in India, has established itself as a leader in reproductive health, urology, and gastroenterology since its founding in 1950. With a strong presence in Europe, North America, and Asia, Ferring is dedicated to developing innovative therapies that address unmet medical needs. The company is renowned for its core products, including hormone therapies and treatments for various gastrointestinal disorders, which are distinguished by their patient-centric approach and commitment to research and development. Ferring's notable achievements include pioneering advancements in assisted reproductive technology, solidifying its market position as a trusted provider of specialised healthcare solutions. Through its dedication to science and patient care, Ferring continues to make significant contributions to the biopharmaceutical industry.
DitchCarbon Score
How does Ferring's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ferring's score of 21 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ferring's reported carbon emissions
Ferring Group, headquartered in India, has made significant commitments towards reducing its carbon emissions, although specific emissions data for the most recent year is currently unavailable. The company has committed to achieving net-zero emissions across all scopes by 2050, with this target being part of its long-term strategy initiated in 2023. Ferring's climate commitments are aligned with the Science Based Targets initiative (SBTi), reflecting its dedication to sustainable practices within the pharmaceuticals, biotechnology, and life sciences sector. The company is actively working towards these goals, having established a framework for emissions reduction that encompasses all scopes of emissions, although specific reduction percentages have not been disclosed. As of now, Ferring does not report any inherited emissions data from a parent company, indicating that its climate strategy is developed independently. The company’s proactive stance on climate action underscores its commitment to environmental sustainability and aligns with industry standards for corporate responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ferring is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
